Deep Chakrabarti
LightNews LightNews
deeponco.bsky.social
Deep Chakrabarti
@deeponco.bsky.social
27 followers 36 following 3 posts
Locum Consultant Uro-Oncology @royalmarsdenNHS, Keen on Football/Aviation/Cats
Posts Replies Media Videos
deeponco.bsky.social
@alison-tree.bsky.social @ccparker.bsky.social #prostatecancer #pcsm
scinews.bsky.social Science News @scinews.bsky.social · Jul 1
This review discusses the contemporary management of all stages of prostate cancer, enabling holistic individualization of treatment, and describes the promise of future research to further improve outcomes.

Open Access
acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
July 1, 2025 at 3:45 PM
deeponco.bsky.social
Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology

@alison-tree.bsky.social @harshanigreen.bsky.social

Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...
June 13, 2025 at 7:14 PM
deeponco.bsky.social
Management of Testicular Cancer

@ascocancer.bsky.social

doi.org/10.1200/OP-2...
May 26, 2025 at 7:29 AM
Reposted by Deep Chakrabarti
alison-tree.bsky.social
Excited to see the HERMES trial results in print www.sciencedirect.com/science/arti...
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uk
HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy
To demonstrate safety and feasibility of 2-fraction stereotactic body radiotherapy (SBRT) for prostate cancer.This single centre, non-comparative, pha…
www.sciencedirect.com
May 23, 2025 at 6:48 AM